Preview

Bashkortostan Medical Journal

Advanced search

PECULIARITIES OF THE CLINICAL COURSE OF HEREDITARY OVARIAN CANCER

Abstract

This article presents the results of our own study of the main clinical signs characteristic of hereditary ovarian cancer (НОС).Material and methods. The selection of patients for the study was carried out by means of a questionnaire in order to identify persons with suspected hereditary nature of the disease. A standard diagnostic panel of DNA, widespread in Russia, intended for the diagnosis of ovarian and breast cancer, was used as an HOC diagnosis. Additionally, targeted sequencing of a new generation wascarried out in patients with negative PCR (polymerase chain reaction) results.Results and discussion. The most significant clinical signs of HOC were: the age of manifestation, the presence of a burdened family and personal cancer history. HOC is significantly more common (p = 0.028) in middle-aged people. The average age of onset of the tumor process was 52.95±11.28 years. HOC is characterized by a burdened family history, and having relatives of the 1st degree of relationship with an oncological history is significantly more in the group of patients with identified germline disorders than in the group without them (p = 0.00033). Malignant neoplasms in relatives by blood in the main group, on average, developed 9 years earlier than in the comparison group (U = 86.5, P = 0.004). The histological subtype specifically attributed to HOC is serous low-grade, endometrioid and undifferentiated carcinomas, but not mucinous ovarian carcinoma, which is more peculiar to ovarian cancer of a non-hereditary nature of the disease.Conclusion. HOC is characterized by an earlier age of onset of the tumor process, a burden of family and personal history.

About the Authors

R. R. Faiskhanova
ГАУЗ «Республиканский клинический онкологический диспансер» Минздрава РБ; ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России
Russian Federation


D. D. Sakaeva
ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России; Клинический госпиталь «Мать и дитя»
Russian Federation


E. K. Khusnutdinova
ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России; ФГБУН «Институт биохимии и генетики» Уфимского федерального исследовательского центра Российской академии наук
Russian Federation


References

1. Наследственный рак молочной железы и/или яичников: ДНК-диагностика, индивидуальный прогноз, лечение и профилактика / Л.Н. Любченко//дис. … д-ра мед. наук: 14.00.14 / Любченко Людмила Николаевна. - М., 2009. - 282 с

2. Наследственный рак яичников: вклад изменений генов-кандидатов в патогенез заболевания /Р.Р. Фаисханова, Д.С. Прокофьева, Э.К. ХуснутдиноваЭ,К [и др.]//Медицинская генетика. - 2019. - Т. 18, №. 11. - С. 3-13

3. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group/ К. Alsop, S. Fereday,C. Meldrum C. [et al.] // J. Clin. Oncol. - 2012. - Vol. 30, № 21. - P. 2654

4. BRCA mutation in high grade epithelial ovarian cancers / T. Manchana, N. Phoolcharoen, P. Tantbirojn // Gynecol. Oncol. Rep. - 2019. - Vol. 29. - P. 102-105

5. The pattern of gene expression in various histotypes of epithelial ovarian cancer correlates with those in the normal fallopian tube, endometrium, and colon /R.T.Marquez, K.A.Baggerly, A.P.Patterson [et al.] // Clin. Cancer Res. - 2005. - Vol. 11, № 17. - P. 6116-6126

6. Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas/A.Niskakoski, S.Kau, Renkonen-Sinisalo L.[et al.]/// Int. J. Cancer. - 2013. - Vol. 133, № 11. - P. 2596-2608

7. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families /D.Ford, D.F.Easton, M. Stratton [et al.]/// Am. J. Hum. Genet. - 1998. - Vol. 62. - P. 676-689


Review

For citations:


Faiskhanova R.R., Sakaeva D.D., Khusnutdinova E.K. PECULIARITIES OF THE CLINICAL COURSE OF HEREDITARY OVARIAN CANCER. Bashkortostan Medical Journal. 2021;16(3):46-50. (In Russ.)

Views: 52


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1999-6209 (Print)